(Q51164233)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486194%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Low dystrophin levels in heart can delay heart failure in mdx mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486194%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486194%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Ingrid Verhaart

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486194%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Annemieke Aartsma-Rus

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486194%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Maaike van Putten

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486194%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Elizabeth M van der Pijl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486194%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Margriet Hulsker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486194%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Vishna D Nadarajah

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486194%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

29 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486194%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486194%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486194%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

17-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24486194%20AND%20SRC:MED&resulttype=core&format=json

Dystrophin and mutations: one gene, several proteins, multiple phenotypes

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Cardiac assessment of patients with late stage Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Duchenne muscular dystrophy: prevalence and patterns of cardiac involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Systemic administration of PRO051 in Duchenne's muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Long-term systemic administration of unconjugated morpholino oligomers for therapeutic expression of dystrophin by exon skipping in skeletal muscle: implications for cardiac muscle integrity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

One-year treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Voluntary exercise induces structural remodeling in the hearts of dystrophin-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Timeline of cardiac dystrophy in 3-18-month-old MDX mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Diaphragm rescue alone prevents heart dysfunction in dystrophic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Primary non-random X inactivation associated with disruption of Xist promoter regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

The effects of low levels of dystrophin on mouse muscle function and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Quantification in cardiac MRI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Brain natriuretic peptide is not predictive of dilated cardiomyopathy in Becker and Duchenne muscular dystrophy patients and carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009

Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.01.009